These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 6230390)

  • 1. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
    Pals ST; Radaszkiewicz T; Gleichmann E
    J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes.
    Rolink AG; Gleichmann E
    J Exp Med; 1983 Aug; 158(2):546-58. PubMed ID: 6224882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.
    Pals ST; Gleichmann H; Gleichmann E
    J Exp Med; 1984 Feb; 159(2):508-23. PubMed ID: 6229596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from lethal graft-vs.-host disease by donor stem cell repopulation.
    Rozendaal L; Pals ST; Melief CJ; Gleichmann E
    Eur J Immunol; 1992 Feb; 22(2):575-9. PubMed ID: 1347016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease.
    Rolink AG; Radaszkiewicz T; Pals ST; van der Meer WG; Gleichmann E
    J Exp Med; 1982 May; 155(5):1501-22. PubMed ID: 6461714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells.
    Lake JP; Kapp JA; Pierce CW
    J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.
    Rus V; Svetic A; Nguyen P; Gause WC; Via CS
    J Immunol; 1995 Sep; 155(5):2396-406. PubMed ID: 7650373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease.
    van Rappard-Van der Veen FM; Kiesel U; Poels L; Schuler W; Melief CJ; Landegent J; Gleichmann E
    J Immunol; 1984 Apr; 132(4):1814-20. PubMed ID: 6321591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids.
    Krzystyniak K; Panaye G; Descotes J; Revillard JP
    Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
    Schattenfroh NC; Hoffman RA; McCarthy SA; Simmons RL
    Transplantation; 1995 Jan; 59(2):268-73. PubMed ID: 7839451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease.
    Via CS
    J Immunol; 1991 Apr; 146(8):2603-9. PubMed ID: 2016521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
    Williamson E; Garside P; Bradley JA; More IA; Mowat AM
    J Immunol; 1997 Aug; 159(3):1208-15. PubMed ID: 9233615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.
    Parkman R
    J Immunol; 1986 May; 136(10):3543-8. PubMed ID: 2871104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 is a central mediator of acute graft-versus-host disease in mice.
    Williamson E; Garside P; Bradley JA; Mowat AM
    J Immunol; 1996 Jul; 157(2):689-99. PubMed ID: 8752918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential cytokine expression in acute and chronic murine graft-versus-host-disease.
    Allen RD; Staley TA; Sidman CL
    Eur J Immunol; 1993 Feb; 23(2):333-7. PubMed ID: 8436168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.